All results / Stories / Amy Stulick


Ventura County Drops to Purple Tier

Ventura County has dropped to the most restrictive COVID-19 reopening framework tier.

First Home COVID Test In Valencia

Ellume’s $30 kit secures approval from the FDA.

Digital diagnostics company Ellume Inc., an Australian company with U.S. operations in Valencia, developed the first at-home COVID-19 test approved by the U.S. Food and Drug Administration.

Two Men Charged With PPP Loan Fraud

Two businessmen from the San Fernando Valley region were named in a federal criminal complaint for alleged participation in a nearly $2 million fraud involving PPP loans.

Carbon Health Opens Testing Site in Simi Valley

Clinic starts with COVID based on current demand.

San Francisco-based urgent care chain Carbon Health opened its first clinic in Ventura County just before Thanksgiving — with its initial focus on COVID-19 testing, according to the company.

Calabasas HR Firm's Partnership Targets Construction Industry

Human resources management provider Arcoro has partnered with Sage Construction and Real Estate.

Medical Supply Company Settles Medicare Fraud Claims

Valley Home Medical Supply Inc. in Canoga Park paid a $565,873 settlement after allegations arose that the company defrauded the federal government's Medicare and Tricare programs.

Scramble to Comply in Tier Changes

COVID surge puts Ventura County back in purple status.

Ventura County was one of 41 counties to drop to the state’s most restrictive reopening framework tier on Nov. 16, joining the rest of Southern California.

For Drug Modeler, French Connection Pays Off

Quarterly report validates Simulations Plus’ acquisition of Lixoft earlier in the year.

Simulations Plus bought French medical software company Lixoft in April, despite a pandemic that hampered in-person communication.

Ventura Lab Hosts Biome Conference

Malibu Microbiome Meeting followed with live Q&A.

Progenabiome in Ventura shared its Malibu Microbiome Meeting earlier this month,

AIDS Healthcare Foundation Protests Amgen Pricing for Orphan Drugs

The AIDS Healthcare Foundation in Los Angeles staged a socially distant protest at Amgen headquarters in Thousand Oaks in response to the biotech giant’s refusal to sell orphan drugs to nonprofit entities at a reduced price.

SBA Loans Debt of Choice During Pandemic

FINANCE: Manufacturing, professional service firms look to buy real estate.

Small businesses have found opportunities during the pandemic, creating a need for capital that SBA lenders have worked to fill.

MannKind Buys QrumPharma for $3.5 Million

MannKind Corp. announced it has acquired Pennsylvania-based QrumPharma Inc. for $3.5 million in cash and more than 3 million shares of its common stock.

Buying into Market Dip to Rebalance Portfolios

One of Jason Sands’ clients asked how he could help others financially during tough times.

Wealth manager Jason Sands sought to keep clients on track for their long-term goals during the year of crisis, while also meeting short-term needs.

Pandemic Workers Need a Money Plan

Firm offers free consultations for medical, retail personnel.

Medical responders and frontline supermarket workers can take advantage of free financial planning through Investor’s Advantage Corp.

Crisis Messaging

PROFILE: Mustang Marketing’s Dianne McKay counsels clients to stay on message during pandemic.

Dianne McKay took the helm as sole owner of Mustang Marketing in April, with the retirement of founder Scott Harris.

Hearing System Approved for Valencia Company

Advanced Bionics in Valencia, in collaboration with fellow Sonova Group subsidiary Phonak, on Thursday announced it has received approval from the Food and Drug Administration to market its cochlear implant technology platform.

Resonance’s Soothing VR Platform

Audio, video calms patients during MRI procedure.

Resonance Technology in Northridge demoed its virtual reality platform at the Radiological Society of North America’s virtual event last year, a bright point for the small medical device manufacturer.

Revenue Rises at Simulations Plus

Drug modeling software company Simulations Plus Inc. enjoyed an increase in revenue compared to last year, while earnings per share remained flat for the fourth financial quarter.

Atara Biotherapeutics Signs Deal With Bayer Worth Up to $610 Million

Atara Biotherapeutics and German pharmaceutical giant Bayer have entered into a strategic collaboration to develop therapies for solid tumors.

Westlake Village BioPartners Debuts Funds With $500 Million

Westlake Village BioPartners has announced two new funds totaling $500 million to invest in life science startups and construct lab facilities for them.